Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

UK medicines regulation: responding to current challenges.

Natalie Richards1, Ian Hudson1

  • 1Medicines and Healthcare products Regulatory Agency, London, UK.

British Journal of Clinical Pharmacology
|September 1, 2016
PubMed
Summary

The UK

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraosseous catheter confirmation with central venous color flow and doppler waveform, a randomized single-blinded trial.

Critical care (London, England)·2026
Same author

An ethnographic study of diagnosis of physical illness in people with mental health conditions in the emergency department.

Social science & medicine (1982)·2026
Same author

COMBAT-TIP: Combat-Optimized Method for Bone Alignment and Tourniquet Innovation in Pelvic Fractures, A Comparative Study on Pelvic Fracture Stabilization.

Wilderness & environmental medicine·2025
Same author

Medical Direction Needs Analysis: Codifying a Medical Directors Course to Meet the Demands of Modern Combat Care.

Military medicine·2025
Same author

An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial.

European urology oncology·2025
Same author

Diagnostic inequalities relating to physical healthcare among people with mental health conditions: a systematic review.

EClinicalMedicine·2025

Area of Science:

  • Pharmaceutical regulation
  • Medical device regulation
  • Public health policy

Background:

  • The regulatory landscape for medicines and medical devices is rapidly evolving due to scientific advancements, globalization, and societal shifts.
  • The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK oversees medicines, medical devices, and blood products to safeguard public health and foster innovation.
  • International collaboration is crucial for regulatory bodies to address global challenges in pharmaceutical and medical device oversight.

Purpose of the Study:

  • To examine current initiatives in the UK and Europe aimed at fostering innovation within medicines regulation.
  • To highlight the MHRA's role in supporting innovators and streamlining regulatory pathways.
  • To discuss the changing nature of regulatory roles towards more flexible and risk-proportionate approaches.

Main Methods:

  • Review of UK and European initiatives supporting regulatory innovation.
  • Analysis of MHRA programs such as the Innovation Office, Early Access to Medicines Scheme, and Accelerated Access Review.
  • Examination of collaborative European efforts like PRIME and Adaptive Pathways.
  • Discussion of strategies to combat counterfeit medicines, including INTERPOL collaboration.

Main Results:

  • The MHRA actively promotes innovation through dedicated offices and simplified regulatory processes, such as the Clinical Trials Regulations and Early Access to Medicines Scheme.
  • European initiatives like PRIME and Adaptive Pathways demonstrate collaborative efforts to accelerate patient access to novel therapies.
  • The MHRA is implementing risk-proportionate, flexible regulatory approaches and enhancing international cooperation to tackle challenges like online sales of counterfeit medicines.

Conclusions:

  • The UK and European regulatory bodies are implementing diverse strategies to accelerate patient access to innovative medicines and medical technologies.
  • The role of regulators is transforming, emphasizing flexibility, risk-proportionate assessments, and robust international collaboration.
  • Continued focus on innovation support and global partnerships is essential for navigating the complexities of modern medicines regulation.

Related Experiment Videos